Epigenetics Programme, Babraham Institute, Cambridge, United Kingdom
Ine Vanderleyden
Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
Silvia Innocentin
Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
Louis Boon
Bioceros BV, Utrecht, Netherlands
Jiong Wang
Division of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States
Martin S Zand
Division of Nephrology, Department of Medicine and Clinical and Translational Science Institute, University of Rochester Medical Center, Rochester, United States
James Dooley
Autoimmune Genetics Laboratory, VIB and University of Leuven, Leuven, Belgium
Jonathan Clark
Biological Chemistry, Babraham Institute, Cambridge, United Kingdom
Adrian Liston
Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom
Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom
Germinal centres (GCs) are T follicular helper cell (Tfh)-dependent structures that form in response to vaccination, producing long-lived antibody secreting plasma cells and memory B cells that protect against subsequent infection. With advancing age the GC and Tfh cell response declines, resulting in impaired humoral immunity. We sought to discover what underpins the poor Tfh cell response in ageing and whether it is possible to correct it. Here, we demonstrate that older people and aged mice have impaired Tfh cell differentiation upon vaccination. This deficit is preceded by poor activation of conventional dendritic cells type 2 (cDC2) due to reduced type 1 interferon signalling. Importantly, the Tfh and cDC2 cell response can be boosted in aged mice by treatment with a TLR7 agonist. This demonstrates that age-associated defects in the cDC2 and Tfh cell response are not irreversible and can be enhanced to improve vaccine responses in older individuals.